Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunomodulatory Effects of Silymarin in Patients With Beta-Thalassemia Major

NCT01752153 is registered in ClinicalTrials.gov with Shiraz University of Medical Sciences as lead sponsor.

NCT NCT01752153
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01752153 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunomodulatory Effects of Silymarin in Patients With Beta-Thalassemia Major
Lead sponsor
Shiraz University of Medical Sciences
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2012
Completion date
September 30, 2012
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immune abnormalities